Indegene Ltd Market Cap ($1.59 Billion)
Market Cap & Net Worth: Indegene Ltd (INDGN)
Indegene Ltd market cap. Indegene Ltd (NSE:INDGN) has a market capitalization of $1.59 Billion (Rs147.27 Billion) as of November 5, 2026. Listed on the NSE stock exchange, this India-based company holds position #6736 globally and #319 in its home market, demonstrating a 1.84% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Indegene Ltd's stock price Rs612.80 by its total outstanding shares 240317117 (240.32 Million). Also see Indegene Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Indegene Ltd Market Cap History (2024–2026)
Indegene Ltd market cap history from 2024 to 2026. Data shows growth from $1.57 Billion to $1.59 Billion (2.90% CAGR). Check INDGN share price today for real-time trading data and today's change.
Index Memberships
Indegene Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY 500
NIFTY500
|
$3.02 Trillion | 0.05% | #275 of 500 |
|
NIFTY SMALLCAP 250
NISM250
|
$388.02 Billion | 0.41% | #91 of 250 |
Weight: Indegene Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Indegene Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Indegene Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Indegene Ltd (INDGN) equity growth momentum to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.05x
Indegene Ltd's market cap is 0.05 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.40x
Indegene Ltd's market cap is 0.40 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.57 Billion | $25.90 Billion | $3.37 Billion | 0.06x | 0.47x |
| 2025 | $1.35 Billion | $28.39 Billion | $4.07 Billion | 0.05x | 0.33x |
| 2026 | $1.59 Billion | $35.10 Billion | $4.01 Billion | 0.05x | 0.40x |
Competitor Companies of INDGN by Market Capitalization
Companies near Indegene Ltd in the global market cap rankings as of November 5, 2026. Also see INDGN total asset value for a full breakdown of the balance sheet.
Key companies related to Indegene Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #718 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1660 globally with a market cap of $14.14 Billion USD ( AU$19.99 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2013 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2073 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #718 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $303.21 |
| #1660 | Pro Medicus Ltd | AU:PME | $14.14 Billion | AU$191.33 |
| #2013 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $77.80 |
| #2073 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $69.84 |
Market Capitalization of Indegene Ltd (2024–2026)
Market capitalization of Indegene Ltd from 2024 to today. Between 2024 and today, Indegene Ltd's market cap moved from $1.57 Billion to $ 1.59 Billion, with a yearly change of 2.90%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs1.59 Billion | +17.74% |
| 2025 | Rs1.35 Billion | -13.79% |
| 2024 | Rs1.57 Billion | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Indegene Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.59 Billion USD |
| MoneyControl | $1.59 Billion USD |
| MarketWatch | $1.59 Billion USD |
| marketcap.company | $1.59 Billion USD |
| Reuters | $1.59 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Indegene Ltd
Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It al… Read more